Updates are available Erratum dated 2017-03-31
Click to view Erratum: https://doi.org/10.1038/nrrheum.2017.51
-
Authors
Winthrop, Kevin L.
- License Information
-
More Information
Article History
First Online: 2 March 2017
Change Date: 31 March 2017
Change Type: Correction
Change Details: In 'Gastrointestinal perforation' of the 'Adverse effects of JAK inhibitors' section, in the sentence “In patients with RA receiving baricitinib, two cases of gastrointestinal perforations were reported (an incidence of 5 cases per 1,000 patient-years in the development program)” the incidence should have been 0.5 cases per 1,000 patient-years. This error has been corrected in the online version of the article.
Competing interests
: The author declares that he has received research support from and has acted as a consultant for Abbvie, Astellis, Galapagos, Lilly, Pfizer, BMS and UCB.
